Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Study Design: Double-blind randomized placebo-controlled clinical trial Study Duration: 2 years Study Center: Single center Hospital de la Santa Creu i Sant Pau, Barcelona Objectives: To assess the effect of Vivomixx® on neuroinflammation and systemic inflammatory response in patients with cirrhosis
Epistemonikos ID: 3e5c1cc5f0b39902cce310cade621465a69834b7
First added on: May 21, 2024